Michael Wang, MD., Ph.D., member of AFCR Scientific Advisory Board Excitement spread quickly after a June 14 report that a COVID-19 vaccine developed by Imperial College London in the U.K. will be tested in humans. What excites people is that the vaccine, which is based on a cutting-edge technology called…...
Will This Drug Relight the Dimming Hope of Finding Effective Therapies for COVID-19?
Michael Wang, MD., Ph.D., member of AFCR Scientific Advisory Board Many people were disappointed by recent high-profile clinical trial results on Remdesivir, the drug that people had put high hopes on as the best candidate for an effective COVID-19 treatment. A report published in The New England Journal of Medicine on…...
Can Vaccines Win the Race Against the Novel Coronavirus?
Michael Wang, MD., Ph.D., member of AFCR Scientific Advisory Board The U.S. death toll has passed the 100,000 mark this week, but effective anti-viral drugs are still not available for the treatment of COVID-19. Rather, many people have been putting their hope on the development of vaccines as Dr. Anthony…...
Don’t Ignore These Ovarian Cancer Related Symptoms
Often known as “the silent killer”, ovarian cancer is difficult to detect early because the ovaries are deep within the pelvis and initial symptoms are often ambiguous and non-specific. Too often the cancer goes undiagnosed until after the disease is far advanced and has spread throughout the abdomen or to…...
Better Treatment Is on the Way as Doctors Know More about the Tricks of Novel Coronavirus
Michael Wang, MD., Ph.D., member of AFCR Scientific Advisory Board On February 11, weeks into the COVID-19 outbreak, the novel coronavirus was officially called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), as most patients showed mild to severe respiratory illness. Doctors shared the same concept, based largely on commonly observed…...
Why Are Men More Vulnerable to COVID-19? Research Is Gradually Uncovering the Truth
Michael Wang, MD., Ph.D., member of AFCR Scientific Advisory Board Early in February, Dr. Sabra Klein, a professor in the Department of Molecular Microbiology and Immunology of the Johns Hopkins Bloomberg School of Public Health, noticed a sex difference in COVID-19 infections based on reports emerging from China. She felt…...
To Do the Therapy & MRI Follow-up or Not in the Midst of COVID-19 Pandemic: “New Normal” Treatment Guidelines for Brain Tumor Patients
Note: This is part two of Dr. Michael Wang’s series that specifically addresses Brain Cancer Treatment during the Coronavirus Pandemic. You can read part one here. Michael Wang, MD., Ph.D., member of AFCR Scientific Advisory Board In addition to surgery, radiation therapy and chemotherapy are the other two major medical procedures…...
To Do the Surgery or Not in the Midst of COVID-19 Pandemic: “New Normal” Treatment Guidelines for Brain Tumor Patients
Michael Wang, MD., Ph.D., member of AFCR Scientific Advisory Board With today being the first day of May, Brain Tumor Awareness Month, I wish to highlight for you a recently produced set of best practices and guidelines pertaining to brain cancer and COVID-19. Glioblastoma, also known as glioblastoma multiforme (GBM), is the…...
